Business
CB2 to Host Virtual Annual General Meeting on September 9, 2020
CB2 to Host Virtual Annual General Meeting on September 9, 2020.

About this update from Skylight Health Group Inc.
[{"type":"text","content":"\n TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) -- CB2 Insights Inc. (“CB2” or the “Company”) (CSE: CBII; OTCQB: CBIIF), one of the largest integrative healthcare systems in the United States, is pleased to announce the webcast details for its Annual General Meeting (the “Meeting”) of the shareholders of the Company. The Meeting will be held virtually on Wednesday September 9, 2020 at 9.00am EST. Due to the ongoing COVID-19 pandemic and to mitigate risks to the health and well-being of our employees, shareholders, communities and other stakeholders, the Meeting will be held virtually through the platform of AGM Connect (http://www.agmconnect.com/). Shareholders and guests can access the virtual meeting through http://www.agmconnect.com/cb2insights2020. Following the business meeting, CB2 management will be providing an operational update and outlook on the business and will invite questions from participants. Registered shareholders are encouraged to attend the Meeting by registering and logging in at least 30 minutes prior to the start of the meeting.  For those unable to attend, a video recording of the meeting will be accessible on the Company’s website at www.CB2insights.com. About CB2 Insights CB2 Insights (CSE:CBII OTCQB:CBIIF) is a healthcare services and technology company, working to positively impact patient health outcomes. With a mission to mainstream alternative health treatments into traditional healthcare by recognizing the need for patient treatment diversity, and the impacts of integrating alternative and conventional medicine. The Company works primarily to roster and treat patients seeking alternative treatments due to the ineffectiveness of conventional medicine, and the inability to find support through their existing care network, or in some cases, inability to access a primary care network. Medical services offered by the Company are defined as Integrative medicine, where we work to understand the real world evidence for the safety, impact and effectiveness of medical treatments including plant based medicines that often lack sufficient research and therefore adoption by conventional healthcare providers. To support patient care and positive health outcomes, the Company is also focused on advancing safety and efficacy research surrounding alternative health treatm...